You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 10, October 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence and Brief Communications
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Melanoma
 •PET/ SPECT Imaging
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Futility of Positron Emission Tomography and Other Modalities in the Initial Radiographic Screening of Patients With Melanoma

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The role of selective sentinel lymphadenectomy is now firmly established as the best method for detecting occult regional melanoma metastases. Furthermore, for asymptomatic patients who have metastases to a sentinel lymph node (SLN), chest radiography; computed tomography of the brain, chest, abdomen, and pelvis; and magnetic resonance imaging of the brain have been shown to have a false-positive rate that well outweighs the true positive (0.5% vs 14%) at the time of selective sentinel lymphadenectomy.1 This discrepancy makes these techniques potentially more harmful than helpful in the initial workup of melanoma patients with regional metastases. In a study by Clark et al,2 none of the 19 patients with positive SLNs had metastases detected by positron emission tomography that could not have been found on routine physical examination. Consequently, it can be inferred that positron emission tomography is no different from other studied imaging methods in detecting occult distant metastases at . . . [Full Text of this Article]


AUTHOR INFORMATION
Edward P. Miranda, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Futility of Fluorodeoxyglucose F 18 Positron Emission Tomography in Initial Evaluation of Patients With T2 to T4 Melanoma
Paige B. Clark, Victoria Soo, Jonathan Kraas, Perry Shen, and Edward A. Levine
Arch Surg. 2006;141(3):284-288.
ABSTRACT | FULL TEXT  

Routine Imaging of Asymptomatic Melanoma Patients With Metastasis to Sentinel Lymph Nodes Rarely Identifies Systemic Disease
Edward P. Miranda, Michael Gertner, James Wall, Elizabeth Grace, Mohammed Kashani-Sabet, Robert Allen, and Stanley P. L. Leong
Arch Surg. 2004;139(8):831-837.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.